GRAL — GRAIL, Inc.
6 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about GRAL (2026-11-05)
- GRAIL reported Q3 2026 financial results with an EPS of -$2.21, missing estimates.
- Revenue was $37.3M, falling short of the $44.0M estimate.
- An FDA Advisory Committee voted in favor of approving the Galleri test.
| Bluesky | 3 | community |
| GDELT | 1 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |